drugset / Trial / NCT05353101
Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial
NaSingle-groupOpen-labelTreatment
Summary
To observe and compare the clinical efficacy of cyclosporine 0.05% eye drops with Loteprednol Etabonate 0.5% and Tobramycin Eye Drops 0.3% in the treatment of Vernal Keratoconjunctivitis in developing regions of China.
Timeline
- Start
- 2020-07-01
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 0.05 % | Topical |
| Subject | Loteprednol Etabonate | Other / unclassified | 0.5 % | Topical |
| Subject | Tobramycin | Small molecule | 0.3 % | Topical |